General Information
Version
3.0
Revision date
2023-08-18
Product name
TANK CLO2 ACTIVATOR SOLUTION
1.2.1 Relevant identified uses
Professional use Industrial/Professional use spec
Manufacturer Name
Tristel Solutions Limited
Emergency telephone
+353 1 809 2566, +353 1 809 2166
Icons in SDS
Company Information
company name
Tristel Solutions Limited
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@tristel.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H302+H312, H312, H315, H318, H412
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Harmful in contact with skin. Harmful if swallowed. Causes skin irritation. Causes serious eye damage. Harmful to aquatic life with long lasting effects.
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS07
Signal word
Danger
Hazard statements
H302+H312 - Harmful if swallowed or in contact with skin. H315 - Causes skin irritation. H318 - Causes serious eye damage. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P280 - Wear protective gloves/protective clothing/eye protection/face protection. P301+P312 - IF SWALLOWED: Call a POISON CENTRE or doctor if you feel unwell. P302+P352 - IF ON SKIN: Wash with plenty of water. P305+P351+P338+P310 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. P332+P313 - If skin irritation occurs: Get medical advice/attention. P273 - Avoid release to the environment.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %